Entera Bio
ENTX · NASDAQ
$3.02+$0.08 (+2.72%)TodayMarket closed ·
Prev close $2.94
Who owns ENTX
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 39.3% of ENTX’s shares.
- BVF Partners L.P.10.0%
- TCG Crossover Management, LLC7.1%
- Vivo Capital, LLC6.9%
- Longitude Capital Management Co., LLC4.6%
- Next 6 largest institutions10.7%
- All other shareholders60.7%
| Holder | Shares | % of shares |
|---|---|---|
| BVF Partners L.P. | 17.23M | 10.00% |
| TCG Crossover Management, LLC | 12.25M | 7.11% |
| Vivo Capital, LLC | 11.82M | 6.86% |
| Longitude Capital Management Co., LLC | 7.84M | 4.55% |
| Knoll Capital Management, LLC | 5.88M | 3.41% |
| D.N.A Biomedical Solutions, Ltd. | 3.73M | 2.17% |
| OPKO Health, Inc. | 3.69M | 2.14% |
| Centillion Fund Inc | 2.40M | 1.39% |
| Seven Fleet Capital Management LP | 1.96M | 1.14% |
| Toledano (Miranda Jayne) | 847.13K | 0.49% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| WEALTHGATE Biotech Fund | 76.56K | 0.04% |
| Fidelity NASDAQ Composite Index Fund | 29.91K | 0.02% |
Short interest
Settled Sep 30, 2026
- Shares short
- 2.40M
- Days to cover
- 5.18
- % of shares outstanding
- 1.40%
- Average daily volume
- 464.32K
- Change since last report
- +87.5%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.